| Name | | Vaccine Category | Disease Indication | Schedules |
ACWY VAX®
[ PI ]
Meningococcal polysaccharide groups A, C, Y and W135 vaccine
|
|
Travel Health
| Meningococcal polysaccharide groups A, C, W135, Y |
1 dose
|
AMBIRIX®
[ PI ]
hepatitis a (inactivated) and hepatitis b(rdna) (hab) vaccine (adsorbed)
|
|
Paediatrics
| Hepatitis A & Hepatitis B |
0, 6-12 months
|
CERVARIX®
[ PI ]
Human Papillomavirus vaccine [Types 16, 18] (Recombinant, adjuvanted, adsorbed)
|
|
HPV
| HPV 16 & 18 |
0, 1, 6 months
|
ENGERIX B®
[ PI ]
Hepatitis B recombinant vaccine, adsorbed
|
|
Travel Health
| Hepatitis B |
0, 1, 6 months 0, 1, 2, 12 months 0, 7, 21 days, 12 months1
|
FLUARIX®
[ PI ]
Influenza vaccine (split virion, inactivated)
|
|
Flu
| Influenza |
1 dose, annually if indicated
|
FENDRIX®
[ PI ]
Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)
|
|
Travel Health
| Hepatitis B |
0, 1, 2, 6 months
|
HAVRIX®
[ PI ]
Hepatitis A vaccines
|
|
Travel Health
| Hepatitis A |
0, 6-12 months, 2nd dose may be given up to 3 years after initial vaccination
|
HEPATYRIX®
[ PI ]
Hepatitis A (inactivated) and Typhoid Polysaccharide vaccine (adsorbed)
|
|
Travel Health
| Hepatitis A & Typhoid |
0, 6-12 months
|
INFANRIX IPV®
[ PI ]
Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed)
|
|
Paediatrics
| Diphtheria, Tetanus, Pertussis, Poliomyelitis |
1 dose
|
MALARONE®
[ PI ]
atovaquone and proguanil hydrochloride
|
|
Travel Health
| Malarial prophylaxis & treatment |
For prophylaxis, once daily, from 1-2 days before travel, to 7 days after travel
|
MENITORIX®
[ PI ]
Haemophilus influenzae type b and Meningococcal group C conjugate vaccine
|
|
Paediatrics
| H.influenza type b & Meningococcal C |
0, 1, 2, 10 months -2 years
|
PRIORIX®
[ PI ]
Measles, Mumps and Rubella vaccine (live)
|
|
Paediatrics
| Measles, Mumps & Rubella |
0, 2nd dose (revaccination) as per national recommendation
|
SYNFLORIX®
[ PI ]
Pneumococcal polysaccharide conjugate vaccine (adsorbed)
|
|
Paediatrics
| Streptococcus pneumoniae |
0, 4, 8 weeks, or 0, 8 weeks in routine programmes + booster ≥ 6 months after last priming dose
|
TWINRIX®
[ PI ]
Hepatitis A (inactivated) and hepatitis B(rDNA) (HAB) vaccine (adsorbed)
|
|
Travel Health
| Hepatitis A & Hepatitis B |
0, 1, 6 months 0, 7, 21 days, 12 months1
|
TYPHERIX®
[ PI ]
Typhoid Polysaccharide vaccine
|
|
Travel Health
| Typhoid |
0, revaccination up to 3 years, for subjects who remain at risk of infection
|
VARILRIX®
[ PI ]
Live attenuated varicella-zoster (Oka strain) virus
|
|
Paediatrics
| Varicella |
0, 6 weeks
|